| Dr David Reynoso, MD, PHD | |
|
301 University Blvd, Galveston, TX 77555-1669 | |
| (409) 772-2222 | |
| Not Available |
| Full Name | Dr David Reynoso |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 12 Years |
| Location | 301 University Blvd, Galveston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205198405 | NPI | - | NPPES |
| 356676202 | Medicaid | TX | |
| 356676201 | Medicaid | TX | |
| 356676203 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | Q3584 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Texas Medical Branch Galveston | Galveston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Medical Branch Faculty Group Practice | 3375456734 | 875 |
News Archive
A recent study published in the Journal of Cancer Epidemiology has reinforced the correlation between being overweight, smoking and breast cancer. What makes this study unique is how test subjects were not diagnosed for BRCA1 and BRCA2 gene mutations, which predispose women to breast cancer.
Of the over 1,900 errors already reported in the gene responsible for cystic fibrosis, it is unclear how many of them actually contribute to the inherited disease. Now a team of researchers reports significant headway in figuring out which mutations are benign and which are deleterious. In so doing, they have increased the number of known CF-causing mutations from 22 to 127, accounting for 95 percent of the variations found in patients with CF.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced enhancements to Reaxys Medicinal Chemistry that address the critical workflow and data challenges of early drug discovery.
The federal government may reimburse doctors for talking to Medicare patients and their families about "advance care planning," including living wills and end-of-life treatment options -; potentially rekindling one of the fiercest storms in the Affordable Care Act debate.
Advances in genetic and genomic testing technology have not only introduced the utilization of clinical genomic information into virtually every area of medical care, this testing has become an essential tool to achieve the goal of precision medicine.
› Verified 3 days ago
| Entity Name | Utmb Faculty Group Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
A recent study published in the Journal of Cancer Epidemiology has reinforced the correlation between being overweight, smoking and breast cancer. What makes this study unique is how test subjects were not diagnosed for BRCA1 and BRCA2 gene mutations, which predispose women to breast cancer.
Of the over 1,900 errors already reported in the gene responsible for cystic fibrosis, it is unclear how many of them actually contribute to the inherited disease. Now a team of researchers reports significant headway in figuring out which mutations are benign and which are deleterious. In so doing, they have increased the number of known CF-causing mutations from 22 to 127, accounting for 95 percent of the variations found in patients with CF.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced enhancements to Reaxys Medicinal Chemistry that address the critical workflow and data challenges of early drug discovery.
The federal government may reimburse doctors for talking to Medicare patients and their families about "advance care planning," including living wills and end-of-life treatment options -; potentially rekindling one of the fiercest storms in the Affordable Care Act debate.
Advances in genetic and genomic testing technology have not only introduced the utilization of clinical genomic information into virtually every area of medical care, this testing has become an essential tool to achieve the goal of precision medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Reynoso, MD, PHD 11511 Shadow Creek Pkwy, Pearland, TX 77584-7298 Ph: (713) 442-0000 | Dr David Reynoso, MD, PHD 301 University Blvd, Galveston, TX 77555-1669 Ph: (409) 772-2222 |
News Archive
A recent study published in the Journal of Cancer Epidemiology has reinforced the correlation between being overweight, smoking and breast cancer. What makes this study unique is how test subjects were not diagnosed for BRCA1 and BRCA2 gene mutations, which predispose women to breast cancer.
Of the over 1,900 errors already reported in the gene responsible for cystic fibrosis, it is unclear how many of them actually contribute to the inherited disease. Now a team of researchers reports significant headway in figuring out which mutations are benign and which are deleterious. In so doing, they have increased the number of known CF-causing mutations from 22 to 127, accounting for 95 percent of the variations found in patients with CF.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced enhancements to Reaxys Medicinal Chemistry that address the critical workflow and data challenges of early drug discovery.
The federal government may reimburse doctors for talking to Medicare patients and their families about "advance care planning," including living wills and end-of-life treatment options -; potentially rekindling one of the fiercest storms in the Affordable Care Act debate.
Advances in genetic and genomic testing technology have not only introduced the utilization of clinical genomic information into virtually every area of medical care, this testing has become an essential tool to achieve the goal of precision medicine.
› Verified 3 days ago
Dr. James Harold Pavela, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-7063 Fax: 409-747-8579 | |
Diaa Hamouda, MBBCH Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Jsa 9.128, Galveston, TX 77555 Phone: 409-772-8031 Fax: 409-772-6940 | |
Syed Mustajab Hasan, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1005 Harborside Drive, Galveston, TX 77555 Phone: 409-762-2328 Fax: 832-632-7866 | |
Arielle Degueure, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883 Fax: 409-747-8579 | |
Dr. Shawn Pua Eiko Nishi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-643-4587 | |
Suyuan Tan, Infectious Disease Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883 | |
Shahzad Jokhio, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-722-2222 |